Ixico plc provides specialist data analytics services to the global biopharmaceutical industry, focusing on the collection, analysis, management, and reporting of data from clinical studies. Its services aim to enhance patient selection, monitor drug safety, and evaluate the clinical efficacy of drug candidates. The company primarily serves clients involved in the development of treatments for neurodegenerative diseases and operates internationally within the biopharmaceutical sector.